Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 10
Submit an article Journal homepage
3,249
Views
47
CrossRef citations to date
0
Altmetric
Original Article

Validity of administrative codes associated with cirrhosis in Sweden

Bonnie Bengtssona Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden;b Unit of Gastroenterology and Rheumatology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3769-3256
ORCID Icon,
Johan Asklingc Rheumatology, Theme Inflammation and Infection, Karolinska University Hospital, Stockholm, Sweden;d Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0003-0433-0616
ORCID Icon,
Jonas F. Ludvigssone Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;f Department of Pediatrics, Örebro University Hospital, Örebro, Sweden;g Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK;h Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-1024-5602
ORCID Icon &
Hannes Hagströma Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden;b Unit of Gastroenterology and Rheumatology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden;d Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0002-8474-1759
ORCID Icon
Pages 1205-1210 | Received 02 Jun 2020, Accepted 01 Sep 2020, Published online: 22 Sep 2020

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tracey G Simon, Sebastian Schneeweiss, Richard Wyss, Zhigang Lu, Lily G Bessette, Cassandra York & Kueiyu Joshua Lin. (2023) Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets. Clinical Epidemiology 15, pages 349-362.
Read now
Hanne Åström, Axel Wester & Hannes Hagström. (2023) Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients. Scandinavian Journal of Gastroenterology 58:8, pages 931-936.
Read now
Sanna Norén, Bonnie Bengtsson, Hannes Hagström, Gunnar Ljunggren & Staffan Wahlin. (2022) Hepatocellular carcinoma in Stockholm, Sweden 2003–2018: a population-based cohort study. Scandinavian Journal of Gastroenterology 57:9, pages 1080-1088.
Read now
Hannes Hagström, Ying Shang, Axel Wester & Linnea Widman. (2022) Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER). Scandinavian Journal of Gastroenterology 57:8, pages 978-983.
Read now

Articles from other publishers (43)

Patrik Nasr, Axel Wester, Mattias Ekstedt, Rickard Strandberg, Stergios Kechagias, Ying Shang, Linnea Widman & Hannes Hagström. (2024) Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis. Clinical Gastroenterology and Hepatology 22:5, pages 1048-1057.e2.
Crossref
Axel Wester, Peter Jepsen & Hannes Hagström. (2024) Statin initiation after myocardial infarction in patients with alcohol‐related liver disease: A nationwide population‐based study. Liver International.
Crossref
Yi-Ting ChenTzu-I Chen, Tsai-Hsuan Yang, Szu-Ching YinSheng-Nan Lu, Xia-Rong LiuYun-Zheng GaoChih-Jo LinChia-Wei Huang, Jee-Fu Huang, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Hwai-I Yang, Ming-Lung Yu & Mei-Hsuan Lee. (2024) Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes. American Journal of Gastroenterology.
Crossref
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag & Hannes Hagström. (2024) Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients. Liver International.
Crossref
Sixian Zhao, Linnea Widman, Hannes Hagström & Ying Shang. (2023) Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study. Addiction 119:4, pages 706-716.
Crossref
Rajani Sharma, Tracey G. Simon, Hannes Hagström, Paul Lochhead, Bjorn Roelstraete, Jonas Söderling, Elizabeth C. Verna, Jean Emond & Jonas F. Ludvigsson. (2024) Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease. Clinical Gastroenterology and Hepatology 22:4, pages 749-759.e19.
Crossref
Hannes Hagström, Ying Shang, Elliot B. Tapper, Axel Wester & Linnea Widman. (2024) Reply. Clinical Gastroenterology and Hepatology 22:3, pages 670.
Crossref
Julian G. Yeh & Philip N. Newsome. (2024) Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study. Hepatology.
Crossref
Camilla Akbari, Maja Dodd, Per Stål, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Johan Vessby, Fredrik Rorsman, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Hannes Hagström & Ying Shang. (2024) Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD. JHEP Reports 6:2, pages 100915.
Crossref
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews & Hannes Hagström. (2024) Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut, pages gutjnl-2023-330962.
Crossref
Nabiha Faisal, Leanne Kosowan, Hasan Zafari, Farhana Zulkernine, Lisa Lix, Alyson Mahar, Harminder Singh, Eberhard Renner & Alexander Singer. (2023) Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases. Canadian Liver Journal 6:4, pages 375-387.
Crossref
Arvid Engström, Viktor Wintzell, Mads Melbye, Henrik Svanström, Björn Eliasson, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Anders Hviid, Peter Ueda & Björn Pasternak. (2023) Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study. Hepatology.
Crossref
Hannes Hagström, Ying Shang, Elliot B. Tapper, Axel Wester & Linnea Widman. (2023) Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients. Clinical Gastroenterology and Hepatology 21:13, pages 3336-3345.e2.
Crossref
Ying Shang, Qing Shen, Elliot B. Tapper, Axel Wester & Hannes Hagström. (2023) Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study. Hepatology Communications 7:11.
Crossref
Fredrik Åberg, Ying Shang, Rickard Strandberg, Axel Wester, Linnea Widman & Hannes Hagström. (2023) Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients. United European Gastroenterology Journal 11:9, pages 852-860.
Crossref
Axel Wester, Ying Shang, Per Stål & Hannes Hagström. (2023) Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study. Hepatology Communications 7:10.
Crossref
Axel Wester, Fredrik Åberg, Rupesh Rajani & Hannes Hagström. (2023) Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study. Clinical Gastroenterology and Hepatology 21:10, pages 2689-2691.e1.
Crossref
Patrik Nasr, Erik von Seth, Raphaela Mayerhofer, Nelson Ndegwa, Jonas F. Ludvigsson & Hannes Hagström. (2023) Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019. European Journal of Epidemiology 38:9, pages 973-984.
Crossref
Hannes Hagström, Maja Thiele, Rajani Sharma, Tracey G. Simon, Bjorn Roelstraete, Jonas Söderling, Johan Sundström & Jonas F. Ludvigsson. (2023) Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease. Clinical Gastroenterology and Hepatology 21:7, pages 1841-1853.e12.
Crossref
Daniel Q. Huang, Norah A. Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi & Rohit Loomba. (2023) Global epidemiology of cirrhosis — aetiology, trends and predictions. Nature Reviews Gastroenterology & Hepatology 20:6, pages 388-398.
Crossref
Axel Wester, Nelson Ndegwa & Hannes Hagström. (2023) Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study. Clinical Gastroenterology and Hepatology 21:5, pages 1271-1280.e7.
Crossref
Fredrik Åberg, Rupesh Rajani, Axel Wester, Linnea Widman & Hannes Hagström. (2023) Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study. Clinical Gastroenterology and Hepatology 21:4, pages 995-1004.e9.
Crossref
Juan Vaz, Ulf Strömberg, Patrik Midlöv, Berne Eriksson, David Buchebner & Hannes Hagström. (2022) Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients. Journal of Internal Medicine 293:2, pages 184-199.
Crossref
Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andreasson, Göran Walldius, Matteo Bottai & Niklas Hammar. (2022) Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers. Alimentary Pharmacology & Therapeutics 57:4, pages 418-425.
Crossref
Ashwin Dhanda, Keith Bodger, Steve Hood, Clive Henn, Michael Allison, Chioma Amasiatu, Robyn Burton, Matthew Cramp, Ewan Forrest, Meetal Khetani, Alastair MacGilchrist, Steven Masson, Richard Parker, Nick Sheron, Ken Simpson, Nikhil Vergis & Martin White. (2022) The Liverpool alcohol‐related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England. Alimentary Pharmacology & Therapeutics 57:4, pages 368-377.
Crossref
Rajani Sharma, Tracey G. Simon, Olof Stephansson, Elizabeth C. Verna, Jean Emond, Jonas Söderling, Bjorn Roelstraete, Hannes Hagström & Jonas F. Ludvigsson. (2023) Pregnancy Outcomes in Women With Autoimmune Hepatitis – A Nationwide Population-based Cohort Study With Histopathology. Clinical Gastroenterology and Hepatology 21:1, pages 103-114.e10.
Crossref
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål & Hannes Hagström. (2022) Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up. Liver International 42:12, pages 2769-2780.
Crossref
Ying Shang, Patrik Nasr, Linnea Widman & Hannes Hagström. (2022) Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology 76:5, pages 1495-1505.
Crossref
Mohsan Subhani, Rebecca Elleray, Jane Bethea, Joanne R. Morling & Stephen D. Ryder. (2022) Alcohol‐related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study. Drug and Alcohol Review 41:6, pages 1331-1340.
Crossref
Daniel A. Burkholder, Isabel J. Moran, Jacob V. DiBattista, Anna S. Lok, Neehar D. Parikh & Vincent L. Chen. (2021) Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Digestive Diseases and Sciences 67:8, pages 3623-3631.
Crossref
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Matteo Bottai, Marianna Kotopouli, Hannes Hagström, Eliane Sardh & Staffan Wahlin. (2022) Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals. Journal of Internal Medicine 291:6, pages 824-836.
Crossref
Tracey G. Simon, Elisabetta Patorno & Sebastian Schneeweiss. (2022) Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes. Clinical Gastroenterology and Hepatology 20:6, pages 1382-1393.e19.
Crossref
Monica Dahiya, Ejemai Eboreime, Ashley Hyde, Sholeh Rahman, Meghan Sebastianski, Michelle Carbonneau, Elliot B. Tapper & Puneeta Tandon. (2021) International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases. Digestive Diseases and Sciences 67:6, pages 2107-2122.
Crossref
Bonnie Bengtsson, Linnea Widman, Staffan Wahlin, Per Stål, Niklas K. Björkström & Hannes Hagström. (2022) The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study. United European Gastroenterology Journal 10:5, pages 465-476.
Crossref
Karl Björkström, Linnea Widman & Hannes Hagström. (2022) Risk of hepatic and extrahepatic cancer in NAFLD : A population‐based cohort study . Liver International 42:4, pages 820-828.
Crossref
Hannes Hagström, Maja Thiele, Rajani Sharma, Tracey G. Simon, Bjorn Roelstraete, Jonas Söderling & Jonas F. Ludvigsson. (2022) Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons. Clinical Gastroenterology and Hepatology 20:4, pages 918-929.e8.
Crossref
Jessica E. Shearer, Juan J. Gonzalez, Thazin Min, Richard Parker, Rebecca Jones, Grace L. Su, Elliot B. Tapper & Ian A. Rowe. (2022) Systematic review: development of a consensus code set to identify cirrhosis in electronic health records. Alimentary Pharmacology & Therapeutics 55:6, pages 645-657.
Crossref
Hannes Hagström, Maja Thiele, Tracey G. Simon, Rajani Sharma, Anna Röckert Tjernberg, Bjorn Roelstraete, Jonas Söderling & Jonas F. Ludvigsson. (2022) Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease. United European Gastroenterology Journal 10:2, pages 198-211.
Crossref
Tracey G. Simon, Hannes Hagström, Rajani Sharma, Jonas Söderling, Bjorn Roelstraete, Emma Larsson & Jonas F. Ludvigsson. (2021) Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. BMC Gastroenterology 21:1.
Crossref
Jeremy Louissaint, Susan L. Murphy, Christopher J. Sonnenday, Anna S. Lok & Elliot B. Tapper. (2021) Applying Administrative Data‐Based Coding Algorithms for Frailty in Patients With Cirrhosis. Liver Transplantation 27:10, pages 1401-1411.
Crossref
Hannes Hagström, Leon A. Adams, Alina M. Allen, Christopher D. Byrne, Yoosoo Chang, Henning Grønbæk, Mona Ismail, Peter Jepsen, Fasiha Kanwal, Jennifer Kramer, Jeffrey V. Lazarus, Michelle T. Long, Rohit Loomba, Philip N. Newsome, Ian A. Rowe, Seungho Ryu, Jörn M. Schattenberg, Marina Serper, Nick Sheron, Tracey G. Simon, Elliot B. Tapper, Sarah Wild, Vincent Wai‐Sun Wong, Yusuf Yilmaz, Shira Zelber‐Sagi & Fredrik Åberg. (2021) Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology 74:1, pages 474-482.
Crossref
Kelly Lee Hayward, Amy L Johnson, Leigh U Horsfall, Chris Moser, Patricia C Valery & Elizabeth E Powell. (2021) Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterology 8:1, pages e000572.
Crossref
Patricia P. Bloom & Elliot B. Tapper. (2020) The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy. Journal of Clinical Medicine 9:11, pages 3620.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.